The post The August 2025 <em>News from ECOG-ACRIN</em> blog is now available appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The FDA has agreed to review GSK’s request to approve Blenrep as a second-line combination treatment for multiple myeloma.| Rare Cancer News
The CAR T-cell therapy Carvykti controlled disease activity in most myeloma patients who hadn't fully responded to standard cell transplant.| Myeloma Research News